Atara Biotherapeutics is a 200+ person publicly traded (Nasdaq: ATRA) clinical-stage biotechnology company. We are co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing hub in northwest Los Angeles) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and office in New York City. Our Southern California hub is anchored by the new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.
People at Atara are high integrity, collaborative, roll-up-your-sleeves types who are deeply committed to putting patients first and advancing medical care with demonstrated urgency. With many accomplished people at Atara, we share humility, flexibility, respect, teamwork, good judgment and being practical in our approach to advance our therapies. We each enjoy in the journey of advancing cutting edge programs, while responsibly teaching and learning together along the way.